ES2107400T1 - Nueva utilizacion terapeutica de superoxidos dismutasas. - Google Patents

Nueva utilizacion terapeutica de superoxidos dismutasas.

Info

Publication number
ES2107400T1
ES2107400T1 ES95941163T ES95941163T ES2107400T1 ES 2107400 T1 ES2107400 T1 ES 2107400T1 ES 95941163 T ES95941163 T ES 95941163T ES 95941163 T ES95941163 T ES 95941163T ES 2107400 T1 ES2107400 T1 ES 2107400T1
Authority
ES
Spain
Prior art keywords
therapeutic use
new therapeutic
dismute
superoxides
sod
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ES95941163T
Other languages
English (en)
Inventor
Francois Baillet
Ioannis Lamproglou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP filed Critical Assistance Publique Hopitaux de Paris APHP
Publication of ES2107400T1 publication Critical patent/ES2107400T1/es
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

NUEVA UTILIZACION TERAPEUTICA DE DISMUTASAS DE SUPEROXIDO (SOD). DICHA PREPARACION BASADA EN SOD CON UNA DURACION PROLONGADA DE LA ACTIVIDAD SE UTILIZA PARA LA OBTENCION DE UN MEDICAMENTO DESTINADO AL TRATAMIENTO O PREVENCION DE PROBLEMAS CEREBRALES PROVOCADOS POR UNA AGRESION CEREBRAL ESPECIFICA O POR UNA AGRESION NO ESPECIFICA.
ES95941163T 1994-11-30 1995-11-29 Nueva utilizacion terapeutica de superoxidos dismutasas. Pending ES2107400T1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9414354A FR2727316B1 (fr) 1994-11-30 1994-11-30 Nouvelle utilisation therapeutique des superoxyde dismutases

Publications (1)

Publication Number Publication Date
ES2107400T1 true ES2107400T1 (es) 1997-12-01

Family

ID=9469309

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95941163T Pending ES2107400T1 (es) 1994-11-30 1995-11-29 Nueva utilizacion terapeutica de superoxidos dismutasas.

Country Status (9)

Country Link
US (1) US5948760A (es)
EP (1) EP0794791A1 (es)
JP (1) JPH11500412A (es)
CN (1) CN1167441A (es)
CA (1) CA2206142A1 (es)
DE (1) DE794791T1 (es)
ES (1) ES2107400T1 (es)
FR (1) FR2727316B1 (es)
WO (1) WO1996016670A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2333785B (en) 1998-01-28 2002-07-31 Baker Hughes Inc Remote actuation of downhole tools using vibration
FR2798622B1 (fr) 1999-09-17 2001-11-02 Mavic Sa Jante de bicyclette et roue comprenant une telle jante
CN112891521A (zh) * 2019-12-04 2021-06-04 凯睿恒济生物医药(杭州)有限公司 锰型高稳定性超氧化物歧化酶在脑卒中预防或治疗中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0653670B2 (ja) * 1985-10-28 1994-07-20 日研フ−ド株式会社 化学療法剤の副作用低減化剤
JPH06199690A (ja) * 1992-03-06 1994-07-19 Yunie:Kk 脳代謝促進・脳機能改善剤

Also Published As

Publication number Publication date
US5948760A (en) 1999-09-07
EP0794791A1 (fr) 1997-09-17
CA2206142A1 (fr) 1996-06-06
CN1167441A (zh) 1997-12-10
FR2727316B1 (fr) 1997-01-24
FR2727316A1 (fr) 1996-05-31
JPH11500412A (ja) 1999-01-12
WO1996016670A1 (fr) 1996-06-06
DE794791T1 (de) 1998-03-05

Similar Documents

Publication Publication Date Title
PT668763E (pt) Utilizacao de fenserina para a preparacao de medicamentos para tratar doencas do conhecimento
PT932398E (pt) Utilizacao do topiramento ou dos seus derivados para a producao de um medicamento para o tratamento de disturbios bipolares maniaco- depressivos
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
DE69528604D1 (de) Medikamentenbehandlung erkrankter tiefliegender bereiche im inneren des körpers
AU5551090A (en) Treatment of ocular disease by modulation of matrix metalloproteinases and their inhibitor
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
PT696205E (pt) Utilizacao de linhas celulares fetais nauro-derivadas para terapia de transplantacao
ES2195220T3 (es) Acidos sulfonilaminocarboxilicos.
EP0151989A3 (en) Means for the treatment of cardiac diseases
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
NO882406D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser.
DK0412554T3 (da) Sustained-release-præparat til administration i hjernen
FI973023A0 (fi) Liikakasvusairauksien yhdistetty terapeuttinen hoito
DE3687097D1 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
DE59409205D1 (de) Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
IT8448983A0 (it) Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ES2107400T1 (es) Nueva utilizacion terapeutica de superoxidos dismutasas.
NO950714L (no) Anvendelse av en tricyklisk forbindelse for fremstilling av medisinske preparater
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.